Next Generation Sequencing – our new study reveals trends, R&D progress, and predicted revenues Where is the Next Generation Sequencing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 248-page report provides 192 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Next Generation Sequencing market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are 4 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Product Types and 5 End Users, each forecasted at a global and regional level.
Global Next Generation Sequencing Market by Application • Drug Discovery • Genetic Screening • Diagnostics • Personalized Medicine • Agriculture and Animal Research • Infectious Diseases • Others
Global Next Generation Sequencing Market by Technology • Whole-Genome Sewuencing • Targeted Re-Sequencing • Exome Sequencing • RNA Seq • Chip Seq • De Novo Sequencing • Methyl Seq • Others
Global Next Generation Sequencing Market by Product • Instruments • Reagents & Consumables • Services
Global Next Generation Sequencing Market by End User • Hospital & Healthcare Institution • Academics • Biotechnology • Pharmaceutical • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets: • North America: • US • Canada
• Latin America: • Brazil • Mexico • Rest of Latin America
• Western Europe: • Germany • The UK • Italy • France • Spain • Nordic • Benelux • Rest of Western Europe
• Eastern Europe: • Russia • Poland • Rest of Eastern Europe
• Asia-Pacific: • Japan • China • India • Australia & New Zealand • ASEAN • Rest of Asia-Pacific
• MEA: • GCC Countries • South Africa • Northern Africa • Rest of MEA
The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth Overall world revenue for Next Generation Sequencing will surpass $5.6bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Next Generation Sequencing Market report helps you In summary, our 248-page report provides you with the following knowledge: • Revenue forecasts to 2027 for 3 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Products and 5 End Users Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 6 regional and 21 key national markets – See forecasts for the Next Generation Sequencing market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa. • Stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Next Generation Sequencing market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Next Generation Sequencing market and leading companies. You will find data, trends and predictions.
Get our report today The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Others), Products (Instruments, Reagents & Consumables, Services), End User (Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others) and Geography.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Introduction
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2 Next-Generation Sequencing Market Overview
2.1 Introduction
2.1.1 Market Definition
2.1.2 Market Taxonomy
2.2 Global Next-Generation Sequencing Market Size and Forecast
2.3 Market Dynamics
2.3.1 Global NGS Market: Drivers
2.3.1.1 Technological Advancements in Sequencing Platforms
2.3.1.2 Increasing Applications of NGS
2.3.1.3 Minimizing Growing Number of Partnerships and Collaborations
2.3.1.4 Increasing Adoption of NGS Technologies among Research Laboratories and Academic Institutes
2.3.1.5 Conferences and Workshops Increasing Awareness on NGS Products and Services
2.3.2 Global Next-Generation Sequencing Market: Restraints
2.3.2.1 Dearth of Skilled Professionals
2.3.2.2 Difficulties in Storage of Sequencing Data
2.3.3 Global Next-Generation Sequencing Market: Opportunity
2.3.3.1 Government Initiatives in Population Sequencing
2.3.3.2 Application of NGS in Precision Medicine & Biomarker Discovery
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
